Kee Song Bio-Technology Holdings Limited reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was TWD 606.36 million compared to TWD 577.34 million a year ago. Net income was TWD 18.83 million compared to TWD 16.42 million a year ago. Basic earnings per share from continuing operations was TWD 0.51 compared to TWD 0.45 a year ago. Diluted earnings per share from continuing operations was TWD 0.51 compared to TWD 0.4 a year ago.